Vitamin B12 100 mg Dosing Duration
For vitamin B12 deficiency without neurological involvement, administer 100 mcg (not mg) intramuscularly three times weekly for 2 weeks, followed by lifelong maintenance therapy every 2–3 months. 1
Critical Clarification on Dose
- The question references "100 mg," but the standard therapeutic dose is 100 mcg (micrograms), which equals 0.1 mg—a 1000-fold difference. 2
- All evidence-based protocols use 100 mcg to 1 mg (1000 mcg) intramuscular hydroxocobalamin or cyanocobalamin. 1, 2
Treatment Algorithm Based on Neurological Status
WITH Neurological Involvement (sensory symptoms, motor dysfunction, gait disturbances, balance problems, visual changes)
- Loading phase: Hydroxocobalamin 1 mg intramuscularly on alternate days until no further clinical improvement occurs. 1, 3
- Maintenance phase: Hydroxocobalamin 1 mg intramuscularly every 2 months for life. 1, 3
- Urgent specialist referral to neurology and hematology is mandatory—do not delay treatment while awaiting consultation. 1, 3
WITHOUT Neurological Involvement
- Loading phase: Hydroxocobalamin 1 mg intramuscularly three times weekly for 2 weeks (total of 6 doses). 1
- Maintenance phase: Hydroxocobalamin 1 mg intramuscularly every 2–3 months for life. 1, 3
FDA-Approved Dosing for Pernicious Anemia
The FDA label for intramuscular vitamin B12 specifies: 2
- Initial treatment: 100 mcg daily for 6–7 days by intramuscular or deep subcutaneous injection.
- Continuation: If clinical improvement and reticulocyte response occur, give 100 mcg on alternate days for 7 doses, then every 3–4 days for 2–3 weeks.
- Maintenance: 100 mcg monthly for life. 2
Important divergence: The FDA protocol uses lower maintenance frequency (monthly) compared to NICE guidelines (every 2–3 months), but both emphasize lifelong therapy. 1, 2
Critical Pitfalls to Avoid
- Never give folic acid before correcting B12 deficiency—this can mask B12 deficiency and precipitate irreversible subacute combined degeneration of the spinal cord. 1, 3
- Do not delay treatment for neurological symptoms while awaiting test results; permanent spinal cord damage can occur. 3
- Avoid intravenous administration—almost all vitamin B12 is lost in urine with IV dosing. 2
- Do not rely on oral supplementation in pernicious anemia or malabsorption conditions; absorption is too unreliable. 2
Oral Dosing Considerations (When Appropriate)
For patients with normal intestinal absorption and no neurological involvement, high-dose oral therapy may be considered: 1, 4, 5
- Treatment dose: 1000–2000 mcg daily sublingual or oral. 1, 6
- Maintenance dose: 250–350 mcg daily or 1000 mcg weekly. 1, 7
- Research shows that 647–1032 mcg daily is required to normalize mild deficiency—over 200 times the RDA. 4
- Even 500 mcg daily for 8 weeks fails to normalize metabolic markers in 15–25% of patients. 5
However, intramuscular therapy remains first-line for established deficiency, particularly post-bariatric surgery or with malabsorption. 1, 2
Monitoring and Long-Term Management
- Lifelong replacement is mandatory regardless of the underlying cause. 1, 3
- Adjust injection frequency based on recurrence of symptoms (sensory changes, fatigue, macrocytic anemia) rather than solely on laboratory values. 3
- In bariatric surgery patients, screen for additional deficiencies (iron, folate, thiamine, fat-soluble vitamins). 1
- In autoimmune contexts (e.g., Addison's disease with pernicious anemia), monitor for other autoimmune conditions including thyroid disease, type 1 diabetes, and celiac disease. 3